[ad_1]
While abroad, such as Germany and Canada, they have announced that they will be vaccinated with the AstraZeneca (AZ) vaccine only at certain ages, the quarantine authorities explained that “they will temporarily stop as long as the entire vaccination schedule is not missed.” Photo shows AstraZeneca Corona 19 vaccine provided by Reuters = Yonhap News
Some countries, such as Germany and Canada, announced a vaccine vaccination policy only at certain ages when rare blood clots were reported after vaccination with the AstraZeneca (AZ) vaccine. In this regard, the quarantine authorities said: “Within the limit that the entire vaccination schedule was not lost, I left it.” This is to prevent the formation of excessive anxiety about the vaccine.
At the Corona 19 Vaccination Response Team’s regular briefing held on the 2nd, Jung Eun-kyung, director of the Korea Centers for Disease Control and Prevention, said: “We are continuously monitoring and investigating the occurrence of similar blood clots (rare after vaccination cases) in Korea and abroad). We will continue to discuss and review the association with the vaccine. ”
In recent years, Germany has changed its guidelines so that only those over 60 are vaccinated with the AZ vaccine, following the recommendations of the Immunization Commission. Canada also recommends vaccinations only for those 55 and older.
In this regard, Professor Na Sang-hoon from the Department of Cardiology at Seoul Medical University said in a regular briefing on the same day: “On the 30th of last month, in Canada and Germany, people under a certain age group they announced that he would not get the Astra vaccine. “” It’s higher, but we’re going to stop Astra for a while as long as we don’t miss the full vaccination schedule due to concerns about certain age groups. ”
On the morning of day 1, Chung Eun-kyung, director of the Korea Centers for Disease Control and Prevention, is inoculating the AstraZeneca (AZ) vaccine at the Heungdeok Health Center in Cheongju, Chungcheongbuk-do to prevent the new coronavirus infection (Corona 19). News 1
Professor Na also said: “On March 18 (local time), the European Medicines Agency (EMA) announced at the beginning of the meeting, and the final conclusion was: ‘The benefit of receiving the vaccine is much greater, but the Uncommon thrombosis number continues to rise. That is why I will control it ”. He said: “There is no change in the final announcement of the 31st (EMA). It’s the same keynote. ”The announcement that EMA believes the AZ vaccine is not at risk for certain age groups is highlighted.
He added: “The expected number of common venous thrombosis in Europe is more than 580, but after AZ vaccination, it has the effect of reducing the overall thrombosis itself to less than a third,” he said. “The incidence of cerebral sinus thrombosis in Korea is 100,000. It is 0.4 per person, which is lower than in Europe. The number of occurrences is expected to be lower.” Furthermore, Professor Na emphasized: “In general, the effect of reducing corona 19 infection itself and reducing deaths after vaccination was announced as a target number.”
Thrombosis in 20 years, normal discharge
Meanwhile, quarantine authorities also released a progress report from Corona 19 responder A, who was reported to have cerebral sinus thrombosis after vaccination on the 16th of last month. Mr. A received the AZ vaccine on the 10th of last month. Symptoms like severe headache didn’t go away even after 4 days. He visited the hospital on the 16th and was diagnosed with cerebral sinus thrombosis. It is a rare thrombosis. It occurs with a frequency of about 1 in 100,000 people in the general population who have not been vaccinated.
As more and more cases complain of specific blood clots after receiving AZ vaccine in Europe etc., quarantine authorities are closely watching the situation. Professor Na said: “I know the patient was discharged from the hospital after symptoms improved on day 22 after anticoagulant treatment, etc.” and “If there are no additional complications, anticoagulant treatment, etc. in the hospital about a week on average. ”
He said, “Because I had a specific thrombosis, such as cerebral venous sinuses, at a young age, I first did hereditary screening and second for various autoantibody diseases.” Prof. Na added: “For the final conclusion, while continuing anticoagulant treatment on an outpatient basis for 3 to 6 months, other tests can be performed to assess the risk of recurrence.”
Reporter Lee Tae-yoon [email protected]
[ad_2]
